Urothelial Carcinoma
📧 Sign up to get email alerts when something new happens for Urothelial Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Study of Sacituzumab Govitecan in Participants With Urothelial Cancer That Cannot Be Removed or Has Spread [Phase 2]
A Phase 2 clinical trial evaluating Sacituzumab Govitecan in patients with metastatic urothelial carcinoma that cannot be removed or has spr…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Avelumab in Combination With AVB-S6-500 in Patients With Advanced Urothelial Carcinoma [Phase 1]
Phase 1 clinical trial evaluating Avelumab in combination with AVB-S6-500 in patients with advanced urothelial carcinoma; current status is …
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Study of Zanzalintinib in Combination With Immuno-Oncology Agents in Participants With Solid Tumors [Phase 1]
A Phase 1 study evaluating Zanzalintinib in combination with immuno-oncology agents in patients with various solid tumors; recruitment is on…
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: Maintenance AVElumab After SECond Line Platinum-based Chemotherapy for Metastatic Urothelial Carcinoma [Phase 2]
Phase 2 trial evaluating maintenance therapy with avelumab after second-line platinum-based chemotherapy in metastatic urothelial carcinoma;…
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: Tocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or Urothelial Carcinoma [Phase 2]
Phase 2 clinical trial update evaluating a triple combination of tocilizumab, ipilimumab, and nivolumab for advanced melanoma, non-small cel…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: Artificial Intelligence-assisted HER2 Expression Assessment in Urothelial Carcinoma Based on Imaging-pathology Omics
An ongoing clinical study sponsored by the Cancer Institute and Hospital, Chinese Academy of Medical Sciences, evaluating AI-assisted HER2 e…
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: A Safety Study of Enfortumab Vedotin in Indian Adults With Urothelial Cancer [Phase 4]
Phase 4 safety study enrolling Indian adults with metastatic urothelial carcinoma to evaluate Enfortumab Vedotin.
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: A Phase 2 Study to Evaluate the Triplet Combination of Pemetrexed Plus AB928 (Etrumadenant) + AB122 (Zimberelimab) in Patients With Previously Treated Advanced or Metastatic MTAP Deficient Urothelial Carcinoma [Phase 2]
Phase 2 study evaluating a triplet combination of pemetrexed, AB928 (etrumadenant), and AB122 (zimberelimab) in previously treated advanced …
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: Nectin-4 Specific LMW PET Probe Imaging in Urothelial Carcinoma [NA]
A clinical trial update for a nectin-4–targeted low-molecular-weight PET probe designed for imaging urothelial carcinoma, which is currently…
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: A Trial of SHR-A2102 With Adebrelimab in Locally Advanced or Metastatic Urothelial Carcinoma [Phase 3]
A Phase 3 trial is evaluating SHR-A2102 in combination with Adebrelimab for locally advanced or metastatic urothelial carcinoma and is curre…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: Using Liquid Biopsy Testing to Identify, Monitor, Predict Recurrence in Urothelial Carcinoma
This clinical trial from Tianjin Medical University Second Hospital aims to use liquid biopsy testing to identify, monitor, and predict recu…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: A Home-Based Prehabilitation Exercise Intervention for Improving Physical Function in Patients With Bladder Cancer and Upper Tract Urothelial Cancer, Get Moving Trial [NA]
This clinical trial status indicates that the Get Moving Trial is recruiting to evaluate a home-based prehabilitation exercise program for p…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Safety and Tolerability Study of 68Ga/177Lu-BRP-020063 in Advanced Solid Tumors [EARLY_Phase 1]
An early-phase, safety and tolerability study of BRP-020063 labeled with gallium-68 and lutetium-177 in advanced solid tumors, including uro…
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: JAVEMACS: Japan AVElumab Maintenance And Continuous Treatment Study
Clinical trial update for the JAVEMACS study evaluating avelumab maintenance and continuous treatment in urothelial carcinoma in Japan. The …
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: Immune Checkpoint Inhibitors With or Without Propranolol Hydrochloride In Patients With Urothelial Carcinoma [Phase 2]
Phase 2 trial evaluating immune checkpoint inhibitors with or without propranolol hydrochloride in urothelial carcinoma; the study is curren…
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: Pembrolizumab Maintenance After Enfortumab Vedotin (EV)/Pembro Induction in Front-Line Metastatic Urothelial Carcinoma [Phase 2]
Phase 2 trial evaluating pembrolizumab maintenance after enfortumab vedotin/pembrolizumab induction as front-line treatment for metastatic u…
-
CLINICAL_TRIALS research · 2026-02-18Clinical Trial Update: A Study of Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Plus Enfortumab Vedotin (EV) With and Without Pembrolizumab in Advanced Urothelial Carcinoma (MK-3475-04C/KEYMAKER-U04) [Phase 1, Phase 2]
Clinical trial update for Phase 1/2 study assessing Sacituzumab Tirumotecan plus Enfortumab Vedotin with or without Pembrolizumab in advance…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Management of Cisplatin-Ineligible Patients With Metastatic Bladder Cancer and The Role of Geriatric Assessments
It discusses strategies for treating metastatic bladder cancer in patients ineligible for cisplatin and examines how geriatric assessments c…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Randomized Trial of stAndard of Care With or Without Metastases-directed Stereotactic Body Radiation Therapy in Patients Affected by Oligometastatic uRothelial carcinomA [NA]
A randomized trial is evaluating whether adding metastasis-directed stereotactic body radiation therapy to standard of care improves outcome…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Clinical Trial to Evaluate Post-Operative Outcomes of Ureteral Stent vs Ureteral Stent Free Radical Cystectomy [NA]
A clinical trial at Thomas Jefferson University is evaluating postoperative outcomes of ureteral stent use versus stent-free radical cystect…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: A Study of Enfortumab Vedotin in People With Urothelial Carcinoma of the Upper Urinary Tract [Phase 2]
A Phase 2 study of Enfortumab Vedotin for urothelial carcinoma of the upper urinary tract is currently recruiting.
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: A Study of Ward Admissions for Haematuria
This clinical trial update shows a study on ward admissions for patients with haematuria that is currently recruiting.
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: A Study of Neuropathy Caused by Enfortumab Vedotin in People With Urothelial Carcinoma
This clinical trial update discusses neuropathy associated with enfortumab vedotin in people with urothelial carcinoma, and the study is cur…
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours [Phase 1]
Phase 1 study evaluating AVA6000 in solid tumors, assessing safety, pharmacokinetics, and early efficacy; recruitment is ongoing across seve…
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: A Real-world Study of the First Treatment and Outcomes of Patients With Advanced or Metastatic Bladder Cancer
Pfizer-sponsored real-world study protocol evaluating initial treatment patterns and outcomes in patients with advanced or metastatic bladde…